Annual Meeting 2022: A New AACR Task Force to Promote Public Trust in Science
The COVID-19 pandemic has provided a strong reminder for the scientific community about the importance of public understanding and...
AACR Annual Meeting 2021: A Recap of Blog Posts
The AACR Annual Meeting 2021 featured the theme “Discovery Science Driving Clinical Breakthroughs.” Indeed, over the course of two weeks,...
Personalized Neoantigen Vaccines Boost Progress Against Aggressive Cancers
Researchers at the AACR Annual Meeting 2024 presented the latest findings regarding two personalized neoantigen cancer vaccines.
AACR Virtual Annual Meeting I: The Promises and Challenges of Expanding the Use of Immune Checkpoint Inhibitors Through Combination Therapy
The cutting-edge scientific program for the AACR Virtual Annual Meeting I began Monday, April 27, with an Opening Clinical Plenary featuring...
AACR Dialogues Spark Important Conversations About Cancer
In the ongoing quest to end cancer health disparities, there’s a simple tool that virtually anyone can use: honest...
NIH-AACR Cancer, Autoimmunity, and Immunology Conference: A Virtual, Multidisciplinary Forum on Immune-related Adverse Events
By Meghali Goswami Meghali Goswami is a PhD candidate in the George Washington University – National Institutes of Health Graduate Partnerships Program and is currently...
Interfacing with the Future: Artificial Intelligence in Oncology
Researchers discussed AI's impact on the diagnosis and treatment of cancer at the AACR Annual Meeting 2024.
AACR Annual Meeting 2023: Clinical Trials of Therapeutic Cancer Vaccines Show Promise
The concept of using vaccination to eradicate cancer by instructing the immune system to eliminate malignant cells has been...
The Best of 2022: FDA Approvals and the Breakthroughs That Enabled Them
The end of the year presents a unique opportunity to look back on recent accomplishments, take inventory of successes...
AACR Virtual Annual Meeting I: Results Presented Provide Basis for FDA Decision to Approve Alternative Pembrolizumab Dosing Schedule
A short time after Mallika Lala, PhD, finished her presentation titled “Pembrolizumab 400 mg Q6W dosing: First clinical outcomes...
Unleashing the Power of CAR T Cells: Insights from Day 3 of AACR IO
The third keynote session at AACR IO highlighted exciting advances in CAR T-cell therapy, including for solid cancers.
Editors’ Picks, December 2025: Potent Molecular Glues, Personalized CAR T-cell Therapies, and More
The countdown to the new year is nearly upon us, but no need to count down to the last...
Faith and Ingenuity: Bringing the First Oncology Clinical Trial to Trinidad
Researchers share lessons from the first oncology clinical trial in Trinidad, which involved a patient named Faith Hill.
Annual Meeting 2022: Advancing Precision Immuno-oncology
“The immuno-oncology revolution is now about 15 years into clinical reality,” said Carl June, MD, FAACR, director of the...
AACR Journal Editors Share “Must Read” Articles for March
While COVID-19 is at the center of medical news, important cancer research findings continue to be reported. As March...
Disparities Conference Unites Researchers, Patients, and Policymakers
As the 15th AACR Conference on The Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved...
New Journal Article Explores Equity in Academia
As the murders of George Floyd, Breonna Taylor, and others exposed racial inequities in America, many sectors of society...
Crystal Mackall: Expanding the Reach of CAR T-cell Therapy
For the sixth time since 2015, researchers, clinicians, drug developers, patient advocates, and other stakeholders convened at the International...
Annual Meeting 2022: Uniting Scientists and Survivors
For more than 20 years, the Scientist↔Survivor Program (SSP) has played a vital role in the American Association for...
Frontiers in Cancer Science: A Stellar Conference in Singapore
by Ashok Venkitaraman, MBBS, PhD Singapore will hold its 15th Frontiers in Cancer Science (FCS) conference November 6-8 at...
Colonoscopy: A Powerful Tool for Cancer Prevention
Guest post by Raymond N. DuBois, MD, PhD, FAACR The headlines stunned many medical professionals, cancer patients, and colorectal...
Addressing Racial Disparities in Multiple Myeloma Clinical Trials and Outcomes During the Pandemic
The word myeloma stems from the Greek word “myelos,” for marrow. Indeed, this type of blood cancer begins in the plasma cells, a type...
Frontiers in Cancer Science—the Singapore Cancer Conference
Guest post by Patrick Casey, PhD, and Joanne Ngeow, BMedSci, MBBS, FRCP, MPH From November 7-9, 2022, Singapore will...
Advances in Malignant Lymphoma Virtual Meeting: Stratifying Risk, Targeting Precursor Cells, Hacking the Epigenome, and More
Virtual scientific meetings have become the “new normal” in the COVID-19 era, enabling researchers to present and discuss recent...
Dr. John D. Carpten: Uncovering Cancer Genetics and Striving to Include Underrepresented Populations in Research
Editor’s note: This story, written by Anna Azvolinsky, first appeared in Leading Discoveries, a magazine and website that raises...
Party With a Purpose 2025 Marks Progress Against Melanoma
This year, Party with a Purpose honors melanoma researchers Lynn Schuchter and Alexander Huang, and humanitarian honoree Patricia Wellenbach.
The Past, Present, and Future of HPV: Can Vaccination Help Eliminate Cervical Cancer?
On a web page titled “14 Diseases You Almost Forgot About (Thanks to Vaccines),” the Centers for Disease Control (CDC) remind us that the...
Pancreatic Cancer: Keynote Highlights Trainees, Rising Stars, and Distinguished Professors
In the opening keynote session of the AACR Special Conference on Pancreatic Cancer, which took place September 27-30 in...
What Biden’s Presidency Will Mean for Cancer Research
Editor’s note: As President Joseph R. Biden Jr. took office on Wednesday, Cancer Discovery, a journal of the American...
Continuing the Conversation on Cancer Disparities
Highlights from a roundtable featuring cancer survivors and researchers discussing cancer disparities and persistent health inequities.